Clinical trial
ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally…
NCT00026364 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00026364 |
|---|---|
| Title | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer |
| Official title | A Phase I Study Of ZD1839 (Iressa) In Combination With Irinotecan, Leucovorin, And 5-Fluorouracil In Previously Untreated, Stage IV Colorectal Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, gefitinib, irinotecan hydrochloride, leucovorin calcium |
| Enrollment | 22 |
| Start date | Nov 1, 2001 |
| Primary completion | Dec 1, 2006 |
| First posted | Jun 25, 2003 |
| Last update posted | Mar 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: